A new case shows that Parkinson's can develop without starting in the brain's smell center

For many years, a leading theory suggested that Parkinson's might actually begin in the nose. The idea was that the condition starts when a trigger, such as a virus or an environmental toxin, enters the body through the nasal passage. From there, it was thought to travel to the olfactory bulb—the part of the brain that processes smell—before spreading further into the brain. Because nearly everyone with Parkinson's loses their sense of smell early on, many scientists wondered if the olfactory bulb was a necessary gateway for the condition to take hold. A recent case report has turned this "nose-first" theory on its head. Researchers identified an individual who was born with a rare condition called isolated congenital anosmia. This person was born without any olfactory bulbs and had never experienced a sense of smell in their entire life. Despite lacking the very structure many thought was the starting point for Parkinson's, this individual developed the typical motor symptoms of the condition in middle age. The discovery is being called a "black swan" event by the scientific community. In science, a black swan is a single observation that proves a long-held theory to be incomplete or incorrect. By documenting a case where Parkinson's appeared without any olfactory bulb input, the study suggests that the condition does not strictly require this nasal pathway to begin. This finding is important because it shifts the focus of research. While the olfactory system is clearly involved for most people, this case proves that there must be other ways the condition can start and spread. It also serves as a reminder to clinicians that while a loss of smell is a common early sign, its absence—or a lifelong lack of it—doesn't rule out the possibility of developing Parkinson's. By looking at these rare cases, researchers can better understand the different ways the condition manifests, moving us closer to more precise ways of diagnosing and eventually treating it for everyone.